Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse DLK-1 ELISA Kit (AC2641)
Cat.#: ASET-1230
Specifications
Description Mouse DLK-1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse DLK-1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 5.67 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1250 Human ASIP ELISA Kit (AC2661) Quantitative inquiry ASET-1346 Mouse Chromogranin B ELISA Kit (AC2757) Quantitative inquiry ASET-1878 Human NMDAR2B ELISA Kit (AC3289) Quantitative inquiry ASET-1438 Human COLEC12 ELISA Kit (AC2849) Quantitative inquiry ASET-1535 Rat Prostate Specific Antigen ELISA Kit (AC2946) Quantitative inquiry ASET-2486 Human Doublecortin ELISA Kit (AC3897) Quantitative inquiry ASET-1029 Human APLP2 ELISA Kit (AC2440) Quantitative inquiry ASET-1617 Mouse GALC ELISA Kit (AC3028) Quantitative inquiry ASET-2105 Human GRK2 ELISA Kit (AC3516) Quantitative inquiry ASET-2092 Rabbit Galectin-3 ELISA Kit (AC3503) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket